Study testing how to give meropenem in the ICU
Treatments studied
This pilot study looks at the best way to give meropenem antibiotic to ICU patients with a serious suspected or confirmed infection. It may help improve treatment timing and dosing to fight infection while in intensive care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be admitted to the ICU at Oslo University Hospital (Rikshospitalet)
- Have a serious suspected or confirmed infection that your care team plans to treat with meropenem
- You (or your next of kin) can provide written informed consent
- You do not have a known allergy to beta-lactam antibiotics (such as some penicillins or related drugs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two common antibiotics, meropenem and piperacillin/tazobactam, to see which works better for adults with sepsis who are critically ill. It aims to help doctors choose the best treatment for serious infections.
This trial tests a new way to quickly measure antibiotic levels in the blood of ICU patients, so doctors can adjust the dose for each person. It aims to make antibiotic therapy more effective and safer.
This trial compares two ways of giving a strong antibiotic (meropenem) to ICU patients with pneumonia and sepsis. It aims to see if giving the drug continuously or in shorter intervals works better. This could help clear the infection faster and improve recovery.
This trial tests a way to give the antibiotic cefepime to ICU patients. It aims to see if the dosing can be adjusted more precisely for each person.
This study tests whether giving antibiotics in a personalized way, based on how your body processes them, works better than the standard dose for treating lung infections in the ICU. If you qualify, you'll be randomly assigned to get either the usual dose or a dose adjusted to your blood levels, with the goal of improving your recovery.
This study tests whether giving an early antibiotic (meropenem) based on a new blood test (PSP) can prevent serious infections (sepsis) in people who come to the emergency department with signs of infection. The goal is to find out if this approach helps them get better faster and avoid more severe illness.
Hear when a new Drug Effect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.